Synthetic peptide substrate assays for hemostasis testing.
D000595:Amino Acid Sequence; D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000032:analysis; D001681:Biological Assay; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005172:Factor XI / Q000032:analysis; D005174:Factor XII / Q000032:analysis; D015951:Factor Xa; D005260:Female; D005341:Fibrinolysin / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008297:Male; D008991:Monitoring, Physiologic; D010314:Partial Thromboplastin Time; D010455:Peptides; D010958:Plasminogen / Q000032:analysis; D010977:Platelet Factor 3 / Q000032:analysis; D010978:Platelet Factor 4 / Q000032:analysis; D011288:Prekallikrein / Q000032:analysis; D011486:Protein C; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis
D000925:Anticoagulants; D006023:Glycoproteins; D010455:Peptides; D011486:Protein C; D010977:Platelet Factor 3; D010978:Platelet Factor 4; D000990:Antithrombin III; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005174:Factor XII; D010958:Plasminogen; D006493:Heparin; D005172:Factor XI; D011288:Prekallikrein; D013917:Thrombin; D015951:Factor Xa; D005341:Fibrinolysin